Main > ONCOLOGY (**) > Lung>NSCLC>Non-Squamous>1st Line > TREAT.: > CN. I. SintiliMAb Inj.+

---

CN. I. SintiliMAb Inj.+'s subsections
(*) CN Approval Date: 2021. 02.03.
+Pemetrexed+Pt CT
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2021. 02.16
PR Web-Site
TradeMark

CN. I. SintiliMAb Inj.+'s products
This section has no products